244 related articles for article (PubMed ID: 6613921)
21. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of vindesine in advanced head and neck cancer.
Cheng E; Young CW; Wittes RE
Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
[TBL] [Abstract][Full Text] [Related]
23. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
[No Abstract] [Full Text] [Related]
24. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
25. Vindesine in the treatment of esophageal carcinoma: a phase II study.
Kelsen DP; Bains M; Cvitkovic E; Golbey R
Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
[TBL] [Abstract][Full Text] [Related]
26. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
[TBL] [Abstract][Full Text] [Related]
27. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of carboplatin in advanced malignant melanoma.
Evans LM; Casper ES; Rosenbluth R
Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of vindesine in patients with malignant melanoma.
Camacho FJ; Young CW; Wittes RE
Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
[No Abstract] [Full Text] [Related]
30. [Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
Domenge C; Richard JM
Ann Otolaryngol Chir Cervicofac; 1984; 101(2):119-21. PubMed ID: 6372615
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of vindesine infusion in visceral metastatic malignant melanoma.
Wagstaff J; Anderson HA; Shiu W; Thatcher N
Cancer Treat Rep; 1983 Sep; 67(9):839-40. PubMed ID: 6883362
[No Abstract] [Full Text] [Related]
32. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
33. Phase II evaluation of vindesine in patients with advanced breast cancer.
Currie VE; Camacho F; Wittes R; Young C
Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
[No Abstract] [Full Text] [Related]
34. Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
Fosså SD; Denis L; van Oosterom AT; de Pauw M; Stoter G
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):473-5. PubMed ID: 6305668
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
36. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
[TBL] [Abstract][Full Text] [Related]
37. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
Van Amburg AL; Presant CA; Burns D
Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
[TBL] [Abstract][Full Text] [Related]
39. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]